MoonLake Immunotherapeuti...

NASDAQ: MLTX · Real-Time Price · USD
54.95
0.07 (0.13%)
At close: Aug 15, 2025, 10:00 AM
0.13%
Bid 54.8
Market Cap 3.49B
Revenue (ttm) 101.85K
Net Income (ttm) -176.47M
EPS (ttm) -2.79
PE Ratio (ttm) -19.7
Forward PE -13.04
Analyst Buy
Ask 55.48
Volume 29,555
Avg. Volume (20D) 531,487
Open 54.88
Previous Close 54.88
Day's Range 54.53 - 55.30
52-Week Range 31.42 - 58.26
Beta 1.27

About MLTX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MLTX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for MLTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
2 months ago
+17.95%
MoonLake Immunotherapeutics shares are trading hig... Unlock content with Pro Subscription
2 months ago
+5.51%
MoonLake Immunotherapeutics shares are trading higher following reports that Merck held talks to acquire the Swiss biotech company for over $3 billion.